| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $138.2B | $134.8B | $134.0B | $136.8B | $133.6B | $128.3B | $34.8B | $34.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $33.8B | $34.1B | $32.7B | $30.1B | $28.7B | $31.6B | $29.9B | $31.1B |
| Operating Income | $29.3B | $28.7B | $22.9B | $30.5B | $32.4B | $28.8B | $6.6B | $0.6B |
| Net Income | $17.2B | $17.5B | $11.6B | $21.3B | $22.1B | $17.8B | $5.1B | $1.9B |
| EPS (Basic) | $4.06 | $4.15 | $2.76 | $5.06 | $5.32 | $4.30 | $1.23 | $0.47 |
| EPS (Diluted) | $4.06 | $4.14 | $2.75 | $5.06 | $5.32 | $4.30 | $1.23 | $0.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $404.3B | $384.7B | $380.3B | $379.7B | $366.6B | $316.5B | $291.7B | $264.8B |
| Current Assets | $56.9B | $40.5B | $36.8B | $37.9B | $36.7B | $54.6B | $37.5B | $34.6B |
| Cash & Equivalents | $19.0B | $4.2B | $2.1B | $2.6B | $2.9B | $22.2B | $2.6B | $2.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $62.4B | $64.8B | $53.2B | $50.2B | $47.2B | $39.7B | $44.9B | $37.9B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $37.1B | $36.9B | $37.5B | $37.1B | $39.5B | $41.8B | $35.7B | $34.3B |
| Investing Cash Flow | $-16.7B | $-18.7B | $-23.4B | $-28.7B | $-67.2B | $-23.5B | $-17.6B | $-17.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-5.6B | $-17.1B | $-14.7B | $-8.5B | $8.3B | $1.3B | $-18.2B | $-15.4B |